SUMITOMO CHEMCL (SOMMY)
(Delayed Data from OTC)
$11.26 USD
+0.10 (0.90%)
Updated Apr 25, 2024 03:45 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for SUMITOMO CHEMCL falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | 21,425 | 22,594 | 20,657 | 20,452 |
Cost Of Goods | NA | 15,350 | 15,454 | 13,691 | 13,958 |
Gross Profit | NA | 6,075 | 7,140 | 6,966 | 6,494 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 6,304 | 5,383 | 5,727 | 5,231 |
Income After Depreciation & Amortization | 0 | -229 | 1,757 | 1,239 | 1,264 |
Non-Operating Income | NA | 524 | 484 | 179 | 121 |
Interest Expense | NA | 293 | 188 | 173 | 186 |
Pretax Income | NA | 2 | 2,052 | 1,245 | 1,199 |
Income Taxes | NA | 349 | 529 | 630 | 699 |
Minority Interest | NA | -399 | 199 | 199 | 216 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -347 | 1,523 | 615 | 500 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 52 | 1,325 | 416 | 284 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 1,014 | 3,037 | 2,467 | 2,474 |
Depreciation & Amortization (Cash Flow) | NA | 1,243 | 1,280 | 1,229 | 1,211 |
Income After Depreciation & Amortization | 0 | -229 | 1,757 | 1,239 | 1,264 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 327.01 | 327.09 | 327.47 | 326.63 |
Diluted EPS Before Non-Recurring Items | NA | 3.67 | 4.05 | 1.27 | 0.87 |
Diluted Net EPS (GAAP) | NA | 0.16 | 4.05 | 1.27 | 0.87 |
Fiscal Year end for SUMITOMO CHEMCL falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 4,198.60 | 4,317.32 | 4,110.94 | 3,843.58 |
Cost Of Goods | NA | NA | NA | 3,168.28 | NA |
Gross Profit | NA | NA | NA | 942.66 | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 1,466.42 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | -523.76 | 0.00 |
Non-Operating Income | NA | NA | NA | 285.95 | NA |
Interest Expense | NA | NA | NA | 126.19 | NA |
Pretax Income | NA | NA | NA | -363.99 | NA |
Income Taxes | NA | NA | NA | 9.64 | NA |
Minority Interest | NA | NA | NA | -131.61 | NA |
Investment Gains/Losses | NA | NA | NA | 0.00 | NA |
Other Income/Charges | NA | NA | NA | 0.00 | NA |
Income From Cont. Operations | NA | -226.40 | -298.30 | -373.63 | 769.96 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -226.40 | -298.30 | -242.02 | 769.96 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 327.12 | 326.27 | 327.11 | 327.03 |
Diluted EPS Before Non-Recurring Items | NA | -0.69 | -0.91 | -0.74 | 2.35 |
Diluted Net EPS (GAAP) | NA | -0.69 | -0.91 | -0.74 | 2.35 |